ROSUHOP-F

Rosuvastan 10 mg + Micronized Fenofibrate 160 mg Tablet

 

Powerful duo in Mixed Dyslipidemia

 

Combinaon reduce Macro & Micro vascular complicaons

Beer clinical efficacy than Rosuvastan monotherapy

 

Indications : Hypercholesterolemia, Hypertriglyceridemia & Lipid abnormality disorders